Heart Test Laboratories
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 15
- Market Cap
- -
- Introduction
Heart Test Laboratories, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded in 2008 and is headquartered in Southlake, TX.
MyoVista wavECG Clinical Evaluation: >=60 y/o Enrichment Population
- Conditions
- Health Screening
- Interventions
- Device: MyoVista wavECG
- First Posted Date
- 2022-05-06
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Heart Test Laboratories, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT05364541
- Locations
- 🇺🇸
University of Texas Medical Center, Dallas, Texas, United States
MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram
- Conditions
- Cardiac Disease
- Interventions
- Device: MyoVista wavECG Test
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Heart Test Laboratories, Inc.
- Target Recruit Count
- 575
- Registration Number
- NCT04804969
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Einstein Medical Center, Philadelphia, Pennsylvania, United States
🇺🇸University of Texas Southwestern Medical Center, Dallas, Texas, United States